Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 9 May 23 EFFECT Notice of effectiveness
- 5 Apr 23 POS AM Prospectus update (post-effective amendment)
- 1 Nov 22 EFFECT Notice of effectiveness
- 31 Oct 22 424B3 Prospectus supplement
- 27 Oct 22 S-4/A Registration of securities issued in business combination transactions (amended)
-
13 Oct 22 S-4 Registration of securities issued in business combination transactions
RCKT similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 24, 2022, with respect to the consolidated financial statements of Renovacor, Inc. included in the joint proxy statement that is made part of the Registration Statement (Form S-4) and Prospectus of Rocket Pharmaceuticals, Inc. for the registration of shares of its common stock.
/S/ ERNST & YOUNG LLP |
Philadelphia, Pennsylvania
October 13, 2022